Clinical Trial Update: Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma

View source ↗

Summary

This Mayo Clinic-sponsored clinical trial in eosinophilic asthma assessed mepolizumab and reports changes in gene transcription and immunophenotypes after treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Eosinophilic Asthma | Status: COMPLETED | Results posted: 2026-03-18